ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Passive

      Invesco Dorsey Wright Healthcare Momentum ETF

      The Invesco Dorsey Wright?Healthcare Momentum ETF (the ¡°Fund¡±) seeks to track the investment results (before fees and expenses) of the Dorsey Wright?Healthcare Technical LeadersTM Index (the ¡°Underlying Index¡±).

      $40.43

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      Dorsey Wright Healthcare Momentum ETF PTH
      Fund Size
      $144M
      Dividend
      -
      Fees
      0.60%
      Total Stock Market Index Fund VTSAX
      Fund Size
      $1.7T
      Dividend
      -
      Fees
      -
      Total Stock Market Index Fund VTI
      Fund Size
      $1.7T
      Dividend
      1.2%
      Fees
      0.03%
      500 Index Fund VFIAX
      Fund Size
      $1.49T
      Dividend
      -
      Fees
      -
      500 Index Fund VOO
      Fund Size
      $1.49T
      Dividend
      1.2%
      Fees
      0.03%
      View 1315 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $19.8B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.07 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.8823
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 73.02
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -19.5
      Profitable Companies 41
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 407.28
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.37
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company -0.67
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT 26.0
      Enterprise Value to Revenue Enterprise value divided by revenue 25.93
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.1
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. -3.7312
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -90.53%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 24.20%
      Return on Assets Indicates a company's profitability in relation to its total assets. -1.25%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -2.37%

      Industries

      Healthcare 76.3%
      Technology 5.3%
      Finance 2.6%
      Industrials 2.6%
      Other 2.6%
      N/A 10.5%

      Market cap

      Micro Cap 11%
      Small Cap 22%
      Mid Cap 43%
      Large Cap 20%
      Mega Cap 4%

      38 Investments

      P/E-Ratio
      Total Investment
      Weight
      Invesco Private Prime Fund logo

      Invesco Private Prime Fund

      P/E-Ratio
      n/a
      Total Investment
      $25.5M
      Weight
      23.5%
      Invesco Private Government Fund logo

      Invesco Private Government Fund

      P/E-Ratio
      n/a
      Total Investment
      $9.82M
      Weight
      9.0%
      Cencora, Inc. logo

      ABC - Wholesale Trade

      Cencora, Inc.

      P/E-Ratio
      29.8
      Total Investment
      $4.65M
      Weight
      4.3%
      Eli Lilly and Co. logo

      LLY - Manufacturing

      Eli Lilly and Co.

      P/E-Ratio
      47.7
      Total Investment
      $4.64M
      Weight
      4.3%
      TG Therapeutics, Inc. logo

      TGTX - Manufacturing

      TG Therapeutics, Inc.

      P/E-Ratio
      71.2
      Total Investment
      $4.47M
      Weight
      4.1%
      Exelixis, Inc. logo

      EXEL - Professional, Scientific, and Technical Services

      Exelixis, Inc.

      P/E-Ratio
      16.9
      Total Investment
      $4.41M
      Weight
      4.1%
      Boston Scientific Corp. logo

      BSX - Manufacturing

      Boston Scientific Corp.

      P/E-Ratio
      62.3
      Total Investment
      $3.99M
      Weight
      3.7%
      Alignment Healthcare, Inc. logo

      ALHC - Finance and Insurance

      Alignment Healthcare, Inc.

      P/E-Ratio
      -63.7
      Total Investment
      $3.83M
      Weight
      3.5%
      BridgeBio Pharma, Inc. logo

      BBIO - Manufacturing

      BridgeBio Pharma, Inc.

      P/E-Ratio
      -12.7
      Total Investment
      $3.79M
      Weight
      3.5%
      Guardant Health, Inc. logo

      GH - Manufacturing

      Guardant Health, Inc.

      P/E-Ratio
      -20.2
      Total Investment
      $3.76M
      Weight
      3.5%
      Axsome Therapeutics, Inc. logo

      AXSM - Manufacturing

      Axsome Therapeutics, Inc.

      P/E-Ratio
      -24.3
      Total Investment
      $3.6M
      Weight
      3.3%
      Krystal Biotech, Inc. logo

      KRYS - Manufacturing

      Krystal Biotech, Inc.

      P/E-Ratio
      29.1
      Total Investment
      $3.6M
      Weight
      3.3%
      Madrigal Pharmaceuticals, Inc. logo

      MDGL - Manufacturing

      Madrigal Pharmaceuticals, Inc.

      P/E-Ratio
      -34.5
      Total Investment
      $3.57M
      Weight
      3.3%
      ResMed Inc. logo

      RMD - Manufacturing

      ResMed Inc.

      P/E-Ratio
      28.7
      Total Investment
      $3.54M
      Weight
      3.3%
      Insmed Inc. logo

      INSM - Manufacturing

      Insmed Inc.

      P/E-Ratio
      -24.9
      Total Investment
      $3.45M
      Weight
      3.2%
      AbbVie Inc. logo

      ABBV - Manufacturing

      AbbVie Inc.

      P/E-Ratio
      98.9
      Total Investment
      $3.41M
      Weight
      3.1%
      Merit Medical Systems, Inc. logo

      MMSI - Manufacturing

      Merit Medical Systems, Inc.

      P/E-Ratio
      45.0
      Total Investment
      $3.15M
      Weight
      2.9%
      Lantheus Holdings, Inc. logo

      LNTH - Manufacturing

      Lantheus Holdings, Inc.

      P/E-Ratio
      13.9
      Total Investment
      $3.14M
      Weight
      2.9%
      Trevi Therapeutics, Inc. logo

      TRVI - Manufacturing

      Trevi Therapeutics, Inc.

      P/E-Ratio
      -20.0
      Total Investment
      $2.98M
      Weight
      2.7%
      Protagonist Therapeutics, Inc. logo

      PTGX - Manufacturing

      Protagonist Therapeutics, Inc.

      P/E-Ratio
      72.1
      Total Investment
      $2.96M
      Weight
      2.7%
      908 Devices Inc. logo

      MASS - Manufacturing

      908 Devices Inc.

      P/E-Ratio
      -12.2
      Total Investment
      $2.93M
      Weight
      2.7%
      Catalyst Pharmaceuticals, Inc. logo

      CPRX - Manufacturing

      Catalyst Pharmaceuticals, Inc.

      P/E-Ratio
      12.1
      Total Investment
      $2.84M
      Weight
      2.6%
      uniQure N.V. logo

      QURE - Manufacturing

      uniQure N.V.

      P/E-Ratio
      -4.5
      Total Investment
      $2.81M
      Weight
      2.6%
      Ocular Therapeutix, Inc. logo

      OCUL - Manufacturing

      Ocular Therapeutix, Inc.

      P/E-Ratio
      -9.7
      Total Investment
      $2.78M
      Weight
      2.6%
      PTC Therapeutics, Inc. logo

      PTCT - Manufacturing

      PTC Therapeutics, Inc.

      P/E-Ratio
      6.1
      Total Investment
      $2.77M
      Weight
      2.5%
      HoMEÔçÒÒŮѸÀ×